ArticleGut pathogens2026
Burden of intestinal protozoan parasites coinciding with Helicobacter pylori infection in patients with gastrointestinal symptoms.
Article in Gut pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimProtozoal infections are underdiagnosed contributors to gastrointestinal disease. As their symptoms frequently overlap with those of Helicobacter pylori infection, a leading cause of gastrointestinal illness, coinfections may be overlooked. This study aimed to determine the prevalence of intestinal protozoal infections among patients referred for H. pylori stool testing and to explore their association with clinical symptoms and risk factors.
methodsA cross-sectional study was conducted on 150 patients presenting with gastrointestinal complaints. Stool samples were examined using comprehensive parasitological techniques, along with ELISA for Entamoeba histolytica/dispar and H. pylori antigens.
resultsIntestinal protozoa were detected in 36.9% of participants, most commonly Blastocystis spp. (33.3%), followed by E. dispar (5.3%) and E. coli (2.7%). Giardia lamblia, Dientamoeba fragilis, and Cyclospora cayetanensis were detected in only four patients. All Entamoeba infections were negative for E. histolytica-specific antigen. H. pylori antigen was positive in 35.3% of participants. The prevalence of intestinal protozoa did not differ significantly between H. pylori-positive and H. pylori-negative patients (39.6% vs. 34%); however, Blastocystis spp. was significantly associated with higher H. pylori antigen concentrations. Both protozoal and H. pylori infections were significantly associated with the source of drinking water but showed no significant association with age or sex. Abdominal pain was the predominant symptom among all patients, regardless of H. pylori or protozoal infection status. Notably, 78% of patients referred for H. pylori testing had not concurrently undergone parasitological examination, of whom 37.6% were subsequently found to have protozoal infections.
conclusionThis study demonstrates a high prevalence of intestinal protozoal infections, predominantly Blastocystis spp., among patients undergoing H. pylori evaluation, and identifies a significant association between Blastocystis and elevated H. pylori antigen levels. The overlapping symptoms and frequent underdiagnosis of protozoal infections in clinical practice support the incorporation of routine parasitological examination alongside H. pylori testing in patients presenting with gastrointestinal symptoms, with the potential to improve diagnostic accuracy and patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.